Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Apr;65(4):10.1002/pbc.26919.
doi: 10.1002/pbc.26919. Epub 2017 Dec 29.

Intracranial metastasis in fibrolamellar hepatocellular carcinoma

Affiliations
Case Reports

Intracranial metastasis in fibrolamellar hepatocellular carcinoma

William J Hammond et al. Pediatr Blood Cancer. 2018 Apr.

Abstract

Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare liver malignancy in adolescents and young adults. Surgery is the mainstay of therapy for primary and metastatic disease. Most patients relapse, with development of both local and distant metastases. Brain metastases from solid tumors are rare in the pediatric and young adult population. Here, we document three patients with brain metastases from FLHCC, confirmed by histology and molecular characterization of the chimeric fusion DNAJB1-PRKACA, each necessitating neurosurgical intervention. These observations highlight the ability of FLHCC to metastasize to the brain and suggest the need for surveillance neuroimaging for patients with advanced-stage disease.

Keywords: adolescent and young adult tumors; brain; fibrolamellar; liver; rare tumors; tumor biology; tumors.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests:

The authors of the manuscript have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Patient 1: Axial (A) T1-weighted contrast-enhanced and sagittal (B) T1-weighted pre-contrast, demonstrate a cystic and solid metastasis within the left frontal lobe resulting in mid line shift. The metastasis contains T1 iso to hyperintense material that are iso to hyperintense on the T2-weighted images consistent with blood products (arrows). Sagittal contrast enhanced T1-weighted images depict the solid enhancing components surrounded by cystic parts of the metastasis. Patient 2: Axial (C) and sagittal (D) reformatted CT images demonstrate a hyperdense hemorrhagic metastasis within the left temporal lobe. Rupture into ventricular system with blood extending into temporal horn of the lateral ventricle [white arrow image (C)]. Edema surrounding the metastasis dark shade of gray designated by black arrows on image (D). Patient 3: Axial (E) and sagittal (F) T1-weighted contrast enhanced images reveal several enhancing metastases (white arrows).
Figure 2
Figure 2
H&E of resected brain metastasis at 10x (A,C,E) and 60x (B,D,F) magnification from Patient 1 (A,B) and Patient 2 (C,D) and Patient 3 (E,F), demonstrating well-differentiated tumor cells with abundant eosinophilic cytoplasm and prominent nucleoli. Fibrous bands, classic for FLHCC are demonstrated in Patient 2 (D, top right corner) and were absent in Patients 1 and 3. Scale bars 100 microns (A,C,E) and 20 microns (B,D,F). RT-PCR agarose gel electrophoresis for the DNAJB1-PRKACA fusion mRNA, is positive for a 148bp amplicon in brain metastases from Patient 1 (lane 2), Patient 2 (lane 3), Patient 3 (lane 4), positive control for DNAJB1-PRKACA (lane 5) and a negative control (lane 6). Lanes are shown from left to right with a 10Kb ladder (lane 1) (G).

References

    1. Eggert T, McGlynn KA, Duffy A, et al. Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database. United European Gastroenterol J. 2013;1:351–7. - PMC - PubMed
    1. El-Serag HB, Davila JA. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology. 2004;39:798–803. - PubMed
    1. Eggert T, McGlynn KA, Duffy A, et al. Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000-10. Gut. 2013;62:1667–1668. - PMC - PubMed
    1. Torbenson M. Fibrolamellar carcinoma: 2012 update. Scientifica. 2012;2012:743790. - PMC - PubMed
    1. Mavros MN, Mayo SC, Hyder O, et al. A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma. J Am Coll Surg. 2012;215:820–30. - PubMed

Publication types

MeSH terms

Substances

Supplementary concepts